Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model

Vaccine

Volumn 32, Issue 4, 2014, Pages 470-477

  Günaydin, Gökçe ^a   Zhang, Ran ^a   Hammarström, Lennart ^a   Marcotte, Harold ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hyperimmune bovine colostrum; Lactobacillus rhamnosus GG; Neonatal mouse model; Probiotic; Protein G; Rotavirus

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G BINDING DOMAIN OF PROTEIN GB1; IMMUNOGLOBULIN G BINDING DOMAIN OF PROTEIN GB2; IMMUNOGLOBULIN G BINDING DOMAIN OF PROTEIN GB3; PROTEIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLOSTRUM; CONTROLLED STUDY; DIARRHEA; FLOW CYTOMETRY; GENE EXPRESSION; GENE REPLICATION; HYPERIMMUNE BOVINE COLOSTRUM; IMMUNIZATION; IN VIVO STUDY; LACTOBACILLUS RHAMNOSUS; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BINDING; PROTEIN EXPRESSION; ROTAVIRUS INFECTION; SCANNING ELECTRON MICROSCOPY; VIRUS LOAD; VIRUS STRAIN; WESTERN BLOTTING; WILD TYPE;

GB1-3; HBC; HBC-IGG; HYPERIMMUNE BOVINE COLOSTRUM; HYPERIMMUNE BOVINE COLOSTRUM DERIVED-IGG ANTIBODIES; IGG; IGG-BINDING DOMAINS GB1, GB2, AND GB3 OF PROTEIN G; IMMUNOGLOBULIN G; LACTOBACILLUS RHAMNOSUS GG; NEONATAL MOUSE MODEL; PROBIOTIC; PROTEIN G; RHESUS ROTAVIRUS; ROTAVIRUS; RRV;

ANIMALS; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CATTLE; COLOSTRUM; DIARRHEA; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; LACTOBACILLUS RHAMNOSUS; MICE; MICE, INBRED BALB C; ROTAVIRUS INFECTIONS; VIRAL LOAD;

EID: 84891626138     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.057     Document Type: Article

References (46)

1. Greenberg H.B., Estes M.K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009, 136:1939-1951.
2. You D., Wardlaw T., Salama P., Jones G. Levels and trends in under-5 mortality, 1990-2008. Lancet 2010, 375:100-103.
3. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J med 2010, 362:289-298.
4. de Palma O., Cruz L., Ramos H., de Baires A., Villatoro N., Pastor D., et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010, 340:c2825.
5. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Jama-J Am Med Assoc 2009, 301:2243-2251.
6. Pant N., Marcotte H., Brussow H., Svensson L., Hammarstrom L. Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 2007, 7:86.
7. Pant N., Marcotte H., Hermans P., Bezemer S., Frenken L., Johansen K., et al. Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea. Future Microbiol 2011, 6:583-593.
8. Ventola H., Lehtoranta L., Madetoja M., Simonen-Tikka M.L., Maunula L., Roivainen M., et al. Effects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats. World J Gastroenterol 2012, 18:5925-5931.
9. Szajewska H., Skorka A., Ruszczynski M., Gieruszczak-Bialek D. Meta-analysis. Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013.
10. Grandy G., Medina M., Soria R., Teran C.G., Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 2010, 10:253.
11. Schiffrin E.J., Blum S. Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 2002, 56(Suppl. 3):S60-S64.
12. Ahmed S., Macfarlane G.T., Fite A., McBain A.J., Gilbert P., Macfarlane S. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 2007, 73:7435-7442.
13. Hammarstrom L. Passive immunity against rotavirus in infants. Acta Paediatr Suppl 1999, 88:127-132.
14. Bogstedt A.K., Johansen K., Hatta H., Kim M., Casswall T., Svensson L., et al. Passive immunity against diarrhea. Acta Paediatr 1996, 85:125-128.
15. Mitra A.K., Mahalanabis D., Ashraf H., Unicomb L., Eeckels R., Tzipori S. Hyperimmune cow colostrum reduces diarrhea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr 1995, 84:996-1001.
16. Bjorck L., Kronvall G. Purification and some properties of streptococcal protein-G, protein-a novel IgG-binding reagent. J Immunol 1984, 133:969-974.
17. Guss B., Eliasson M., Olsson A., Uhlen M., Frej A.K., Jornvall H., et al. Structure of the IgG-binding regions of streptococcal protein G. EMBO J 1986, 5:1567-1575.
18. Douagi I., McInerney G.M., Hidmark A.S., Miriallis V., Johansen K., Svensson L., et al. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. J Virol 2007, 81:2758-2768.
19. Brussow H., Hilpert H., Walther I., Sidoti J., Mietens C., Bachmann P. Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol 1987, 25:982-986.
20. Olsson A., Eliasson M., Guss B., Nilsson B., Hellman U., Lindberg M., et al. Structure and evolution of the repetitive gene encoding streptococcal protein G. Eur J Biochem 1987, 168:319-324.
21. Martin M.C., Pant N., Ladero V., Gunaydin G., Andersen K.K., Alvarez B., et al. Integrative expression system for delivery of antibody fragments by Lactobacilli. Appl Environ Microbiol 2011, 77:2174-2179.
22. Kruger C., Hu Y., Pan Q., Marcotte H., Hultberg A., Delwar D., et al. In situ delivery of passive immunity by Lactobacilli producing single-chain antibodies. Nat Biotechnol 2002, 20:702-706.
23. Andersen K.K., Marcotte H., Alvarez B., Boyaka P.N., Hammarstrom L. In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing Lactobacilli. BMC Biotechnol 2011, 11:126.
24. Pant N., Hultberg A., Zhao Y., Svensson L., Pan-Hammarstrom Q., Johansen K., et al. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis 2006, 194:1580-1588.
25. Aladin F., Einerhand A.W., Bouma J., Bezemer S., Hermans P., Wolvers D., et al. In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PloS One 2012, 7:e32949.
26. Majerowicz S., Kubelka C.F., Stephens P., Barth O.M. Ultrastructural study on experimental infection of rotavirus in a murine heterologous model. Mem Inst Oswaldo Cruz 1994, 89:395-402.
27. Kubelka C.F., Marchevsky R.S., Stephens P.R., Araujo H.P., Oliveira A.V. Murine experimental infection with rotavirus SA-11: clinical and immunohistological characteristics. Exp Toxicol PatholV 45 1994, 433-438.
28. Offit P.A., Clark H.F., Kornstein M.J., Plotkin S.A. A murine model for oral infection with a primate rotavirus (simian SA11). J Virol 1984, 51:233-236.
29. Burns J.W., Krishnaney A.A., Vo P.T., Rouse R.V., Anderson L.J., Greenberg H.B. Analyses of homologous rotavirus infection in the mouse model. Virology 1995, 207:143-153.
30. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Wang S., et al. Protection against rotavirus infections by DNA vaccination. J Infect Dis 1996, 174(Suppl. 1):S93-S97.
31. Boshuizen J.A., Reimerink J.H., Korteland-van Male A.M., van Ham V.J., Koopmans M.P., Buller H.A., et al. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol 2003, 77:13005-13016.
32. Kuchipudi S.V., Tellabati M., Nelli R.K., White G.A., Perez B.B., Sebastian S., et al. 18S rRNA is a reliable normalisation gene for real time PCR based on influenza virus infected cells. Virol J 2012, 9:230.
33. Wang F., Wang J., Liu D., Su Y. Normalizing genes for real-time polymerase chain reaction in epithelial and nonepithelial cells of mouse small intestine. Anal Biochem 2010, 399:211-217.
34. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002, 29:23-39.
35. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193.
36. Duval M., Lewis C.J., Nomellini J.F., Horwitz M.S., Smit J., Cavacini L.A. Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus. Antimicrob Agents Chemother 2011, 55:5547-5552.
37. Hultberg A., Temperton N.J., Rosseels V., Koenders M., Gonzalez-Pajuelo M., Schepens B., et al. Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PloS One 2011, 6:e17665.
38. Eriksson A., Norgren M. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 2003, 71:211-217.
39. Tokuhara D., Alvarez B., Mejima M., Hiroiwa T., Takahashi Y., Kurokawa S., et al. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest 2013, 123:3829-3838.
40. Robinson K., Chamberlain L.M., Lopez M.C., Rush C.M., Marcotte H., Le Page R.W., et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 2004, 72:2753-2761.
41. Bermudez-Humaran L.G., Nouaille S., Zilberfarb V., Corthier G., Gruss A., Langella P., et al. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl Environ Microbiol 2007, 73:5300-5307.
42. Corthesy B., Boris S., Isler P., Grangette C., Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 2005, 192:1441-1449.
43. Lagenaur L.A., Sanders-Beer B.E., Brichacek B., Pal R., Liu X., Liu Y., et al. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol 2011, 4:648-657.
44. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006, 4:754-759.
45. Otto W., Najnigier B., Stelmasiak T., Robins-Browne R.M. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol 2011, 46:862-868.
46. Sarker S.A., Casswall T.H., Mahalanabis D., Alam N.H., Albert M.J., Brussow H., et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J 1998, 17:1149-1154.